Cargando…
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
To identify approaches to target DNA repair vulnerabilities in cancer, we discovered nanomolar potent, selective, low molecular weight (MW), allosteric inhibitors of the polymerase function of DNA polymerase Polθ, including ART558. ART558 inhibits the major Polθ-mediated DNA repair process, Theta-Me...
Ejemplares similares
-
Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
por: Rodriguez-Berriguete, Gonzalo, et al.
Publicado: (2023) -
Resistance to DNA repair inhibitors in cancer
por: Baxter, Joseph S., et al.
Publicado: (2022) -
Chronic immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a systematic review
por: Barron, Carly C, et al.
Publicado: (2023) -
The Principles of Treatment by Radiotherapy in Breast Carcinoma
por: McWhirter, R.
Publicado: (1950) -
The Value of Post-Operative Radiotherapy in Carcinoma of the Breast
por: McWhirter, R.
Publicado: (1943)